Loading...
 
Toggle Health Problems and D

Breast cancer associated with Vitamin D Receptor (14th study) – Oct 2019

Int J Vitam Nutr Res. 2019 Oct 18:1-9. doi: 10.1024/0300-9831/a000615.
Francis I1, AlAbdali N2, Kapila K1, John B1, Al-Temaimi RA1.
1 Department of Pathology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
2 Postgraduate Medical Sciences Program, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.

VitaminDWiki

1.9X higher risk in this study

The risk of 44 diseases at least double with poor Vitamin D Receptor as of Oct 2019


Vitamin D Receptor and Cancers includes:

Items in both categories Vitamin D Receptor and Cancer - Breast:


Vitamin D Receptor Activation can be increased by any of:
Resveratrol, Omega-3, Magnesium, Zinc, non-daily Vitamin D dosing, curcumin, intense exercise, etc
   Note: The founder of VitaminDWiki uses 10 of the 12 known VDR activators

Vitamin D deficiency is an emerging risk factor for breast cancer suggesting its role in breast cancer pathogenesis. Recent evidence suggests vitamin D receptor (VDR) expression is a prognosis predictor in breast cancer. We set out to determine the status of VDR expression in histologically characterized breast cancers, and whether common genetic variants modify VDR expression in breast cancer. One-hundred and twenty Kuwaiti female breast cancer fixed tissues were assessed for VDR expression to identify the level and location of its expression by immunohistochemistry. VDR variants (rs731236, rs2228570), and vitamin D binding protein (VDBP) variants (rs4588, rs7041) genotypes were ascertained in breast cancer specimens using Taqman genotyping assays. VDR nuclear expression correlated with low grade tumors (p = 0.01), whereas cytoplasmic expression correlated with lymph node positive tumors (p = 0.03). Absence of VDR expression was a marker for high-grade dedifferentiated tumors (p = 0.01). VDBP rs7041 associated with breast cancer risk (OR 1.92, 95% CI: 1.34 - 2.73; p = 0.0004), and VDR rs2228570 correlated with increased VDR cytoplasmic expression (p < 0.0001). In conclusion, VDR expression is altered in breast cancer confirming its involvement in breast cancer progression. Genetic factors appear to play a role in breast cancer risk, and may modify tumor sensitization to vitamin D.


Created by admin. Last Modification: Saturday November 9, 2019 13:52:24 GMT-0000 by admin. (Version 8)